Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function—new warnings

New warnings due to risk of hyperkalaemia, hypotension, and impaired renal function have been agreed following an EU-wide review.